Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA
doi:10.1186/s13643-016-0259-8 21
Detailed stages of the cycle: CPT-1 (outer mitochondrial membrane): Acyl-CoA + L-carnitine Acyl-carnitine + CoA-SH Rate limiting enzyme Inhibited by malonyl-CoA Isoforms: CPT-1A (liver), CPT-1B (muscle), CPT-1C (brain) CACT (translocase): Transport of acylcarnitine into the matrix Antiport with free carnitine The only transporter for acylcarnitines CPT-2 (inner mitochondrial membrane): Acyl-carnitine + CoA-SH Acyl-CoA + L-carnitine Regeneration of acyl-CoA in the matrix Not regulated by malonyl-CoA -oxidation (matrix): Cyclic shortening of the acyl chain Products: acetyl-CoA, FADH2, NADH CPT-1 regulation Research on Cell Cultures L-carnitine tested on various cell types: Cardiomyocytes: main source of energy from -oxidation Myotubes (C2C12): skeletal muscle metabolism Hepatocytes: ketogenesis and gluconeogenesis Adipocytes: lipolysis and lipid metabolism Cancer cells: Warburg metabolism vs
Moreover, IGF-1 LR3s ability to modulate glucose metabolismby restricting glucose transport into cellsencourages the use of fat as an energy source, facilitating significant fat loss
Medical office staff, prescribing physicians, and clinical supervisors typically handle these forms to maintain continuity of care for their patients and ensure compliance with utilization management protocols
The liver has 50% of each AMPK isoform (1 and 2), while adipose tissue expresses higher levels of the AMPK1 isoform [93]
